arrow
P

Philippe Vielh

department of pathology
H指数:67
被引数:1.7万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Design and analytical validation of Nexthyro 2.0, a custom next-generation sequencing panel integrating DNA mutation profiling and RNA fusion detection for routine thyroid pathology specimens

Nexthyro 2.0的设计与分析验证,一种定制化下一代测序panel,整合DNA突变分型和RNA融合检测,用于常规甲状腺病理标本

2026-08-310
OAAI
The World Health Organization Reporting System for Lymph Node, Spleen, and Thymus Cytopathology: Part 2-Spleen and Thymus

世界卫生组织淋巴节点、脾脏和胸腺细胞病理学报告系统:第2部分-脾脏和胸腺

2025-10-010
PRE
The Benefit of Combining Docetaxel with Androgen Deprivation Therapy in Localized and Metastatic Hormone-sensitive Prostate Cancer is Predicted by ERG Expression: An Analysis of Two GETUG Phase 3 Trials

联合多西他赛与雄激素剥夺疗法在局部性和转移性激素敏感性前列腺癌中的获益由ERG表达预测:对两项GETUG III期试验的分析

2024-07-010
PRE
The 5th edition of The World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms (vol 36, pg 1720, 2022)

世界卫生组织第5版血淋巴肿瘤分类: 淋巴肿瘤 (第36卷,1720页,2022)

LEUKEMIA
IF13.4
2023-07-1915
OAAI
Adipose Tissue Properties in Tumor-Bearing Breasts
2020-08-218
OAAI
An Accessible and Unique Insight into Metastasis Mutational Content Through Whole-exome Sequencing of Circulating Tumor Cells in Metastatic Prostate Cancer

通过转移性前列腺癌中循环肿瘤细胞的全外显子组测序对转移突变内容的可访问和独特见解

2020-08-0124
OAAI
High-Throughput Genomics and Clinical Outcome in Hard-to-Treat Advanced Cancers: Results of the MOSCATO 01 Trial
2017-06-01529
OAAI